Literature DB >> 17629736

Upregulation of VEGF in subchondral bone of necrotic femoral heads in rabbits with use of extracorporeal shock waves.

Huan-Zhi Ma1, Bing-Fang Zeng, Xiao-Lin Li.   

Abstract

Extracorporeal shock wave treatment appears to be effective in patients with avascular necrosis of the femoral head. However, the pathway of biological events whereby this is accomplished has not been fully elucidated. The purpose of this study was to investigate the effect of extracorporeal shock waves on vascular endothelial growth factor (VEGF) expression in necrotic femoral heads of rabbits. VEGF expression was assessed by immunohistochemistry, quantitative real-time PCR, and Western blot analysis. The degree of angiogenesis was also assessed, as determined by the microvessel density (MVD), the assessment of which was based on CD31-expressing vessels. Bilateral avascular necrosis of femoral heads was induced with methylprednisolone and lipopolysaccharide in 30 New Zealand rabbits. The left limb (the study side) received shock wave therapy to the femoral head. The right limb (the control side) received no shock wave therapy. Biopsies of the femoral heads were performed at 1, 2, 4, 8, and 12 weeks. Western blot analysis and real-time PCR showed that shock wave therapy significantly increased VEGF protein and mRNA expression, respectively, in the subchondral bone of the treated necrotic femoral heads. Compared with the contralateral control without shock wave treatment, the VEGF mRNA expression levels increased to a peak at 2 weeks after the shock wave treatment and remained high for 8 weeks, then declined at 12 weeks, whereas the VEGF protein expression levels increased to a peak at 4 weeks after the shock wave treatment and remained high for 12 weeks. The immunostaining of VEGF was weak in the control group, and the immunoreactivity level in the shock-wave-treated group increased at 4 weeks and persisted for 12 weeks. The most intensive VEGF immunoreactivity was observed in the proliferative zone above the necrotic zone. At 4, 8, and 12 weeks after the shock wave treatment, MVD in subchondral bone from treated femoral heads was significantly higher than that in subchondral bone from untreated femoral heads. These data clearly show that extracorporeal shock waves can significantly upregulate the expression of VEGF. The upregulation of VEGF may play a role in inducing the ingrowth of neovascularization and in improving the blood supply to the femoral head.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17629736     DOI: 10.1007/s00223-007-9046-9

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  32 in total

1.  A volleyball player with bilateral knee osteochondritis dissecans treated with extracorporeal shock wave therapy.

Authors:  Biagio Moretti; Angela Notarnicola; Lorenzo Moretti; Paola Giordano; Vittorio Patella
Journal:  Chir Organi Mov       Date:  2009-04-28

2.  Study of vascular injuries using endothelial denudation model and the therapeutic application of shock wave: a review.

Authors:  Cheuk-Kwan Sun; Pei-Lin Shao; Ching-Jen Wang; Hon-Kan Yip
Journal:  Am J Transl Res       Date:  2011-04-08       Impact factor: 4.060

3.  Genetic association of angiogenesis- and hypoxia-related gene polymorphisms with osteonecrosis of the femoral head.

Authors:  Jung Min Hong; Tae Ho Kim; Hyun Ju Kim; Eui Kyun Park; Eun Kyoung Yang; Shin Yoon Kim
Journal:  Exp Mol Med       Date:  2010-05-31       Impact factor: 8.718

4.  Physical Stimulations for Bone and Cartilage Regeneration.

Authors:  Xiaobin Huang; Ritopa Das; Avi Patel; Thanh Duc Nguyen
Journal:  Regen Eng Transl Med       Date:  2018-06-25

5.  Effect of extracorporeal shockwave therapy (ESWT) on pulpal blood flow after orthodontic treatment: a randomized clinical trial.

Authors:  Frank Falkensammer; Wolfgang Schaden; Christoph Krall; Josef Freudenthaler; Hans-Peter Bantleon
Journal:  Clin Oral Investig       Date:  2015-07-17       Impact factor: 3.573

6.  Prognostic factors of extracorporeal shock wave therapy for tendinopathies.

Authors:  A Notarnicola; G Maccagnano; S Tafuri; A Fiore; C Margiotta; V Pesce; B Moretti
Journal:  Musculoskelet Surg       Date:  2015-05-16

7.  Extracorporeal shock wave therapy effectively protects brain against chronic cerebral hypo-perfusion-induced neuropathological changes.

Authors:  Han-Tan Chai; Kuan-Hung Chen; Christopher Glenn Wallace; Chih-Hung Chen; Pei-Hsun Sung; Yung-Lung Chen; Chun-Man Yuen; Pei-Lin Shao; Cheuk-Kwan Sun; Hsueh-Wen Chang; Ching-Jen Wang; Mel S Lee; Hon-Kan Yip; Sheung-Fat Ko
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

Review 8.  The use of extracorporeal shock waves in the treatment of osteonecrosis of the femoral head: a systematic review.

Authors:  Eneida Machado Alves; Adriano Tanajura Angrisani; Mittermayer B Santiago
Journal:  Clin Rheumatol       Date:  2009-07-17       Impact factor: 2.980

9.  Impact of extracorporeal shock wave therapy (ESWT) on orthodontic tooth movement-a randomized clinical trial.

Authors:  Frank Falkensammer; Christoph Arnhart; Christoph Krall; Wolfgang Schaden; Josef Freudenthaler; Hans-Peter Bantleon
Journal:  Clin Oral Investig       Date:  2014-02-19       Impact factor: 3.573

10.  Fresh-stored osteochondral allografts for the treatment of femoral head defects: surgical technique and preliminary results.

Authors:  Yona Kosashvili; Guy Raz; David Backstein; Oren Ben Lulu; Allan E Gross; Oleg Safir
Journal:  Int Orthop       Date:  2013-04-04       Impact factor: 3.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.